Limits...
Assessing the effect of an interactive decision-aid smartphone smoking cessation application (app) on quit rates: a double-blind automated randomised control trial protocol.

BinDhim NF, McGeechan K, Trevena L - BMJ Open (2014)

Bottom Line: Daily smokers aged 18 and above will be randomised into one of the subapps after completing the baseline questionnaire.Abstinence rates will be measured at 10 days, 1 month, 3 months and 6 months, with the 1-month follow-up abstinence rate as the primary outcome.This study was approved by the University of Sydney's Human Ethics Committee.

View Article: PubMed Central - PubMed

Affiliation: School of Public Health, University of Sydney, Sydney, New South Wales, Australia Public Health and Health Informatics School, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia.

No MeSH data available.


Related in: MedlinePlus

Screenshots of the study app (A is a screenshot of the baseline questionnaire, B a quitting benefits tracker, C a notification message when a quitting benefit accomplished and D the follow-up process).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4120407&req=5

BMJOPEN2014005371F1: Screenshots of the study app (A is a screenshot of the baseline questionnaire, B a quitting benefits tracker, C a notification message when a quitting benefit accomplished and D the follow-up process).

Mentions: This is an automated, double-blind, RCT to determine the efficacy of a self-help, interactive, decision-aid smartphone smoking cessation app compared with an app that contains only smoking cessation information. A single app has been developed (figure 1) that includes the baseline questionnaire and two subapps: the intervention and control apps. After completing the baseline questionnaire, eligible participants will be automatically randomised to one of the subapps.


Assessing the effect of an interactive decision-aid smartphone smoking cessation application (app) on quit rates: a double-blind automated randomised control trial protocol.

BinDhim NF, McGeechan K, Trevena L - BMJ Open (2014)

Screenshots of the study app (A is a screenshot of the baseline questionnaire, B a quitting benefits tracker, C a notification message when a quitting benefit accomplished and D the follow-up process).
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4120407&req=5

BMJOPEN2014005371F1: Screenshots of the study app (A is a screenshot of the baseline questionnaire, B a quitting benefits tracker, C a notification message when a quitting benefit accomplished and D the follow-up process).
Mentions: This is an automated, double-blind, RCT to determine the efficacy of a self-help, interactive, decision-aid smartphone smoking cessation app compared with an app that contains only smoking cessation information. A single app has been developed (figure 1) that includes the baseline questionnaire and two subapps: the intervention and control apps. After completing the baseline questionnaire, eligible participants will be automatically randomised to one of the subapps.

Bottom Line: Daily smokers aged 18 and above will be randomised into one of the subapps after completing the baseline questionnaire.Abstinence rates will be measured at 10 days, 1 month, 3 months and 6 months, with the 1-month follow-up abstinence rate as the primary outcome.This study was approved by the University of Sydney's Human Ethics Committee.

View Article: PubMed Central - PubMed

Affiliation: School of Public Health, University of Sydney, Sydney, New South Wales, Australia Public Health and Health Informatics School, College of Health Sciences, Saudi Electronic University, Riyadh, Saudi Arabia.

No MeSH data available.


Related in: MedlinePlus